Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study
Benjamin A. Fisher(University Hospitals Birmingham NHS Foundation Trust), Antónia Szántó(University of Debrecen), Wan‐Fai Ng(Newcastle upon Tyne Hospitals NHS Foundation Trust), Michele Bombardieri(Queen Mary University of London), Maximilian Posch(Charité - Universitätsmedizin Berlin), Athena Papas(Tufts University), Arwa M. Farag(Tufts University), Thomas Daikeler(University Hospital of Basel), Bettina Bannert(University Hospital of Basel), Diego Kyburz(University Hospital of Basel), Alan Kivitz(Altoona Center for Clinical Research), Steven E. Carsons(Winthrop-University Hospital), David Isenberg(University College Hospital), Francesca Barone(University Hospitals Birmingham NHS Foundation Trust), Simon Bowman(University Hospitals Birmingham NHS Foundation Trust), Pascal Espié(Novartis (Switzerland)), David Floch(Novartis (Switzerland)), Cyrielle Dupuy(Novartis (Switzerland)), Xiaohui Ren(Novartis (Switzerland)), P. Faerber(Novartis (Switzerland)), A. Wright(Novartis (Switzerland)), Hans Hockey, Michael Rotte(Novartis (Switzerland)), Julie Milojevic(Novartis (Switzerland)), Alexandre Avraméas(Novartis (Switzerland)), Marie‐Anne Valentin(Novartis (Switzerland)), James S. Rush(Novartis (Switzerland)), P Gergely(Novartis (Switzerland))
Cited by 121
Abstract
Related Papers
No related papers found
Powered by citation graph analysis